To the Editor,
In this Letter to the Editor, I would like to raise a few questions related to the views on SARS-CoV-2 behavior seen through the eyes of a perinatologist in response to the article published in your Journal [1]. The article in question gives a realistic perspective on current situation of COVID-19 pandemic and is an excellent basis for discussion in the field of perinatology.
What is partial similarity between COVID-19 infection and pathology seen in perinatology?
The origin of the problem in preeclampsia or hereditary thrombophilia is found in the uteroplacental unit: antiangiogenic factors are increased, angiogenic ones are reduced. Vascular endothelial growth factor, placental growth factor, insulin growth factor, and insulin binding plasma protein are reduced. As a consequence of misbalance in the formation of old and new blood vessels, plasma protein 13 and C reactive protein increase. Is it possible that SARS-CoV-2 induces reaction of blood vessels for itself?
Moreover, SARS-CoV-2 primarily attacks the lungs and kidneys afterwards. Are there any similarities with the spongy appearance of the placenta? What connects all these organs is good vascularization and presence of small blood vessels with good blood supply to the tissues. Which tissues are less attacked by SARS-CoV-2? What is their protection?
How to treat conditions that predispose uteroplacental passage disorders in order to prevent blood vessel thrombosis, inflammation, hypoxia, and hypoxemia? We administer anticoagulant and antiplatelet therapy, just like in COVID-19 infection.
Finally, many pathologies seen in pregnancy such as preeclampsia or HELLP syndrome are multisystem diseases just like COVID-19 and could be approached in a similar manner.
How can we find similarity between stem cells and SARS-CoV-2?
SARS-CoV-2 behaves as a stem cell ‘learning’ our organism. It imposes its growth dynamics and genome on the environment. The virus avoids cells that are ‘under tobacco’ as they appear to be not healthy enough for ‘laying down the host – the virus’. After growing stronger they can manage their life and reproduction even in those tissues, more powerful, not even looking for tissues with more oxygen.
Smokers are more resistant for now, since their lung environment is ‘dirty to nestle in’ and ‘spread its young’. In the previous stage during 2020, the virus has learned how to get by and reproduce even in cells with less oxygen. Imagine that this agent known as “virus” is actually a hedgehog. When the whole hedgehog enters the body it insidiously moves until it anchors and multiplies in a human as a ‘host’. It behaves like an embryonic stem cell and a malignant cell at the same time. It then provokes extremely strong reaction and triggers an immune response ‘of cell capture and cell self-destruction’. The cells fight with inflammation which eventually leads to ischemia (general lack of oxygen) especially in the lungs but also in all organs.
What are diagnostic missteps?
Clinical autopsies are banned on the basis of what data? Contagiousness? What are we losing? Timely diagnosis? Won’t the PPE and adequate room protection be enough for the researchers as well as for the clinicians? Wouldn’t tissue examination help? If the lungs ‘disappear’ after 24 or 48 h, does the virus continue to destroy and turn other tissues ‘into stone’? Are all tissues and all cells and organs occupied by this ‘multiplied virus’? In addition, the PCR test is sometimes negative if the agent has already descended into the lungs, or if it is present in a small amount in the nose, and antigen tests can be false negative quite often, which is why we need to look for better and more precise diagnostics.
What about therapy and vaccination?
Vaccinators will have to unite more professionally than politically in WHO (which has already been compromised). In essence it is better to be vaccinated than to get COVID-19 infection even though most vaccines have emergency authorization up to this moment. Could SARS-CoV-2 that ‘masters’ and ‘intelligently understands our genome’ take up new model od RNA for at least some time and make up new protective proteins therefore imposing greater evil of revaccination every six months to a year? From the Marvel-like philosophical point of view, the virus as an aggressor seeks a good area to multiply and lay down its young, so when it takes over the whole human body and destroys it, the aggressor can hardly wait to jump on the next organism. Similarly to an army of the cubs that have become adults, so every cell of the human body is no longer enough for them to continue to lay their young, and new bases are sought to move in and reproduce further.
The use genetic engineering always raises an ethical question of misuse of the scientific advancement implemented for COVID-19 fight in genetic corrections of the methabolopaties in embryos, and as a community we should always be aware of that.
In conclusion, the raise of COVID-19 infection and its treatments should be approached by a multidisciplinary team, similarly like in perinatology with great regard to ethical standards.
-
Research funding: None declared.
-
Author contributions: Single author contribution.
-
Competing interests: Author states no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Not applicable.
Reference
1. Volpe, N, Luca Schera, GB, Dall’Asta, A, Di Pasquo, E, Ghi, T. COVID-19 in pregnancy: where are we now? J Perinat Med 2021;49:637–42. https://doi.org/10.1515/jpm-2021-0309.Search in Google Scholar PubMed
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Corner of Academy
- Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies
- Adverse perinatal outcomes following the prenatal diagnosis of isolated single umbilical artery in singleton pregnancies: a systematic review and meta-analysis
- Original Articles – Obstetrics
- Perinatal outcomes in women with severe acute respiratory syndrome coronavirus 2 infection: comparison with contemporary and matched pre-COVID-19 controls
- The postpartum period during the COVID-19 pandemic: investigating Turkish women’s postpartum support and postpartum-specific anxiety
- First-line noninvasive management of cytomegalovirus primary infection in pregnancy
- Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
- Improved management of placenta accreta spectrum disorders: experience from a single institution
- A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- The impact of preimplantation genetic testing for aneuploidy on prenatal screening
- Original Articles – Fetus
- Myocardial deformation analysis in late-onset small-for-gestational-age and growth-restricted fetuses using two-dimensional speckle tracking echocardiography: a prospective cohort study
- HDlive Flow Silhouette with spatiotemporal image correlation for assessment of fetal cardiac structures at 12 to 14 + 6 weeks of gestation
- Umbilical artery pulsatility index and half-peak systolic velocity in second- and third-trimester fetuses with trisomy 18 and 13
- Original Articles – Neonates
- Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation
- Outcomes from birth to 6 months of publicly insured infants born to mothers with severe acute respiratory syndrome coronavirus 2 infection in the United States
- Placental findings are not associated with neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy – an 11-year single-center experience
- High frequency band limits in spectral analysis of heart rate variability in preterm infants
- Bacterial DNA detection in very preterm infants assessed for risk of early onset sepsis
- Short Communication
- Healthcare workers’ attitudes about vaccination of pregnant women and those wishing to become pregnant
- Letter to the Editors
- Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- Re: Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- SARS-CoV-2 behavior, through the eyes of a perinatologist?
- Re: SARS-CoV-2 behavior, through the eyes of a perinatologist?
Articles in the same Issue
- Frontmatter
- Corner of Academy
- Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies
- Adverse perinatal outcomes following the prenatal diagnosis of isolated single umbilical artery in singleton pregnancies: a systematic review and meta-analysis
- Original Articles – Obstetrics
- Perinatal outcomes in women with severe acute respiratory syndrome coronavirus 2 infection: comparison with contemporary and matched pre-COVID-19 controls
- The postpartum period during the COVID-19 pandemic: investigating Turkish women’s postpartum support and postpartum-specific anxiety
- First-line noninvasive management of cytomegalovirus primary infection in pregnancy
- Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
- Improved management of placenta accreta spectrum disorders: experience from a single institution
- A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- The impact of preimplantation genetic testing for aneuploidy on prenatal screening
- Original Articles – Fetus
- Myocardial deformation analysis in late-onset small-for-gestational-age and growth-restricted fetuses using two-dimensional speckle tracking echocardiography: a prospective cohort study
- HDlive Flow Silhouette with spatiotemporal image correlation for assessment of fetal cardiac structures at 12 to 14 + 6 weeks of gestation
- Umbilical artery pulsatility index and half-peak systolic velocity in second- and third-trimester fetuses with trisomy 18 and 13
- Original Articles – Neonates
- Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation
- Outcomes from birth to 6 months of publicly insured infants born to mothers with severe acute respiratory syndrome coronavirus 2 infection in the United States
- Placental findings are not associated with neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy – an 11-year single-center experience
- High frequency band limits in spectral analysis of heart rate variability in preterm infants
- Bacterial DNA detection in very preterm infants assessed for risk of early onset sepsis
- Short Communication
- Healthcare workers’ attitudes about vaccination of pregnant women and those wishing to become pregnant
- Letter to the Editors
- Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- Re: Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- SARS-CoV-2 behavior, through the eyes of a perinatologist?
- Re: SARS-CoV-2 behavior, through the eyes of a perinatologist?